Leukemia Trials Need Broader Populations, FDA/ASH Workshop Suggests

Acute leukemia trials should include a more heterogeneous population, according to panelists at a June 24 workshop sponsored by FDA and the American Society of Hematology

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet